[Federal Register Volume 86, Number 184 (Monday, September 27, 2021)]
[Notices]
[Pages 53308-53309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20844]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-21-0210; Docket No. CDC-2021-0102]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a continuing 
information collection project titled List of Ingredients Added to 
Tobacco in the Manufacture of Cigarette Products. The proposed 
collection allows CDC's Office of Smoking and Health (OSH) to collect 
information about the ingredients used in cigarette products, a 
responsibility that has been delegated to CDC by HHS.

DATES: CDC must receive written comments on or before November 26, 
2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0102 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed 
above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    List of Ingredients Added to Tobacco in the Manufacture of 
Cigarette Products (OMB Control No. 0920-0210, Exp. 4/30/2022)--
Extension--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP),

[[Page 53309]]

Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Cigarette smoking is the leading preventable cause of premature 
death and disability in our nation. Each year more than 480,000 deaths 
occur as the result of cigarette smoking-related diseases. The CDC's 
Office on Smoking and Health (OSH) is the lead federal agency for 
comprehensive tobacco prevention and control. Since 1986, as required 
by the Comprehensive Smoking Education Act (CSEA) of 1984, which 
amended the Federal Cigarette Labeling and Advertising Act (FCLAA), 15 
U.S.C. 1335a, CDC has collected information about the ingredients used 
in cigarette products. HHS has delegated responsibility for 
implementing the required information collection to CDC's OSH. 
Respondents are commercial cigarette manufacturers, packagers, or 
importers (or their representatives), who are required by FCLAA to 
submit ingredient reports to HHS on an annual basis.
    Respondents are not required to submit specific forms; however, 
they are required to submit a list of all ingredients used in their 
products. CDC requires the ingredient report to be submitted by 
chemical name and Chemical Abstract Service (CAS) Registration Number, 
consistent with accepted reporting practices for other companies 
currently required to report ingredients added to other consumer 
products. The information collected is subject to strict 
confidentiality provisions.
    Ingredient reports are due annually on March 31. Information is 
submitted to CDC by mailing or faxing a written report on the 
respondent's letterhead. All faxed lists should be followed up with a 
mailed original. Electronic mail submissions are not accepted. Mail 
Annual Ingredient Submissions to Attention: FCLAA Program Manager, 
Office on Smoking and Health, National Center for Chronic Disease 
Prevention and Health Promotion, Centers for Disease Control and 
Prevention, 4770 Buford Highway NE, MS S107-7, Atlanta, GA 30341-3717.
    Upon receipt and verification of the annual ingredient report, CDC 
issues a Certificate of Compliance to the respondent. As deemed 
appropriate by the Secretary of HHS, HHS is authorized to use the 
information to report to Congress the health effects of ingredients, 
research activities related to the health effects of ingredients, and 
other information that the Secretary determines to be of public 
interest.
    There are no costs to respondents other than their time. The total 
estimated annualized burden hours are 358. OMB approval is requested 
for three years.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Business Entities.............  N/A.............              55               1             6.5             358
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             358
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-20844 Filed 9-24-21; 8:45 am]
BILLING CODE 4163-18-P